Press Releases

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the first RefluxStop™ procedures have been performed in another leading reflux center of excellence in the Puglia region in Italy – IRCCS Saverio De Bellis – the fourth center of excellence to start in Italy within a couple of months.

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that two independent scientific presentations on RefluxStop™ patient data were delivered at the 2023 SCS meeting in Basel in June 7-9, 2023.  

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that the world-renowned anti-reflux surgeon, Professor Luigi Bonavina from IRCCS Policlinico San Donato Hospital in Milan, Italy completed his first two RefluxStop™ procedures recently.

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that Medtop recognized RefluxStop™ as the most innovative medical device among all competitors.

Today, May 25, 2023, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general meeting resolved to adopt all of the board of directors’ resolution proposals. A summary of the resolutions adopted at the general meeting is set out below.

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med. Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site’s RefluxStop™ results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world’s premier meeting for gastrointestinal professionals

RefluxStop™ - Designed for a Revolution in the Care of Acid Reflux

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that CIO Bulletin identified and recognized Implantica as one of the “50 Admired Companies to Watch in 2023”.

Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The interim report for the first quarter will be published at 8:00 a.m. CET on the same day.

The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 25, 2023, at 15:00 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.